All three H2020 projects (FANCI, ChildBrain, ENRICH) involve tracking human attention and behavior, consistent with Tobii's core eye tracking business.
TOBII AB
Swedish eye tracking technology company providing gaze interaction hardware and software for research in human-computer interaction, health, and accessibility.
Their core work
Tobii is a Swedish SME specializing in eye tracking technology and gaze-based human-computer interaction. In H2020 projects, they contributed eye tracking hardware and software expertise to research on natural computer interaction (FANCI), children's neurocognitive disorders (ChildBrain), and communication across the lifespan (ENRICH). Their role is consistently that of a technology provider, supplying sensing and interaction tools to research-driven consortia working on human behavior analysis and assistive communication.
What they specialise in
FANCI focused explicitly on face and body analysis for natural computer interaction.
ENRICH addressed enriched communication across the lifespan, an area where gaze-based input serves users with motor impairments.
ChildBrain studied children's neurocognitive disorders, where eye tracking provides objective behavioral measurements.
How they've shifted over time
Tobii's H2020 participation is concentrated in a narrow window (2015–2016 start dates), making it difficult to identify a clear evolution. Their projects span from digital interaction (FANCI) to health-adjacent neuroscience and communication research (ChildBrain, ENRICH), suggesting a broadening from pure technology development toward applied research in health and accessibility. No projects appear after 2016, which may indicate a shift away from H2020 participation or toward other funding instruments.
Tobii moved from core digital interaction R&D toward health and accessibility applications of eye tracking, though their H2020 activity ended early in the programme.
How they like to work
Tobii has never coordinated an H2020 project — they join as participant or third party, contributing specialized technology to larger research consortia. With 26 unique partners across 12 countries from just 3 projects, they connect into broad European networks without leading them. This is typical of a commercial technology provider that offers its products and expertise as an enabling component rather than driving the research agenda.
Despite only 3 projects, Tobii has collaborated with 26 partners across 12 countries, reflecting the large consortium sizes typical of MSCA and Innovation Action projects. Their network spans broadly across Europe without a strong geographic concentration.
What sets them apart
Tobii is the dominant commercial eye tracking company in Europe, making them a rare industry partner that brings a mature, market-ready product into research consortia rather than just prototypes. For consortium builders, partnering with Tobii means access to professional-grade gaze tracking hardware, validated software platforms, and a direct path to commercial deployment of research outputs involving eye or attention tracking.
Highlights from their portfolio
- FANCIThe only project with recorded EC funding (EUR 432,250), focused on Tobii's core domain of face and body analysis for natural computer interaction.
- ENRICHA 4-year MSCA training network on communication across the lifespan, connecting eye tracking technology to real-world accessibility and health challenges.